The Food Safety Authority of Ireland (FSAI) (Irish: Údarás Sábháilteachta Bia na hÉireann – USBE) is the statutory body responsible for ensuring food produced, distributed or marketed in Ireland complies with food safety and hygiene standards, best practice codes and legal requirements.The FSAI was established on 1 January 1999, with the enactment of the Food Safety Authority of Ireland Act, 1998. The chief executive of the FSAI is Dr. Pamela Byrne.The FSAI Act empowers the Authority to issue closure orders and prohibition orders on food businesses which do not comply with food safety and hygiene requirements.
This article reviews cases of severe bezoar formation linked to specific enteral nutrition products used for tube-feeding in hospitalised, undernourished patients. The French agency ANSES identified nine cases between 2009 and 2023, including life-threatening incidents and one death, prompting a safety alert to healthcare professionals and manufacturers. The article highlights the risk of bezoar formation, especially in patients with slowed digestive transit or those on certain medications, and recommends further studies by manufacturers as well as increased vigilance and reporting of adverse effects in clinical practice.
This investigation focuses on exploring the physicochemical characteristics and antimicrobial activity of loofah honey in the Egyptian governorates of Kafr El-Shaikh and El-Beheira. A novel variety of honey, designated as a supplementary resource, has been identified as a means of sustenance for bees during periods of scarcity. Pollen analysis of the examined honey samples revealed its natural origin from various plant sources in trace amounts. The physicochemical analysis produced noteworthy results, with estimated reducing sugars ranging from 61.10±0.20 to 69.29±0.12 g/100g and pH values varying between 3.53±0.01 and 3.74±0.01. There were notable variations amongst the samples in terms of free acidity, total lactone, and total acidity, while no significant distinctions were noted in ash content. The study further identified the highest recorded values for H2O2, DN, and HMF as 76.80±0.01 mg/kg, 12.50±0.06 U/kg, and 5.35±0.01 mg/kg, respectively. Additionally, the maximum levels of phenols, flavonoids, and DPPH were determined as 210.56±0.01 mg/kg, 52.84±0.01 mg/kg, and 83.33±0.01 %, respectively. In terms of antimicrobial activity, all samples exhibited efficacy against Bacillus subtilis and Klebsiella pneumoniae, except for one sample that demonstrated antimicrobial activity against all six tested microorganisms’ types.
Diet-related noncommunicable diseases (NCDs) are a leading cause of ill-health and death across Europe. In Ireland, dietary intakes of saturated fat, free sugar and salt exceed World Health Organization recommendations, and excess consumption follows a social gradient increasing population risk of diet-related NCDs. The retail food environment can influence consumer food choice and subsequent dietary intakes. In high income countries, supermarkets are an increasingly influential actor in consumer food availability, choice, purchase, and subsequent food intake. This study aims to assess the relative availability and prominence of healthy and unhealthy foods in Irish supermarkets, by area-level deprivation. This study used a cross-sectional study design, and applied a validated measure, as described in the INFORMAS Protocol: Food Retail – Food availability in supermarkets. Between October 2021 and February 2022, shelf space (m2) (height or depth (cm) × length (cm)) and prominence (visibility), of foods, classified as healthy and unhealthy and represented by a proxy indicator, were collected in supermarkets (n = 36) in County Dublin, Ireland. Overall the proportion of mean relative shelf space (m2), allocated to healthy and unhealthy foods, and its prominence, by area-level deprivation, and retailer, were determined. We used t-tests and one-way ANOVA to analyse possible differences between the proportion of relative shelf space available to healthy and unhealthy foods, and its prominence, by area-level deprivation and retailer. The study found the proportion of shelf space measured allocated to unhealthy food was 68.0
The European Food Safety Authority (EFSA) collaborated with the Food Safety Authority of Ireland (FSAI) to plan and run a simulation exercise to rehearse a multi-agency, multi-Member State response under Regulation (EU) 2022/2371 on Serious Cross Border Threats to Health (SCBTH). Engaging with EFSA's training contractor, Instinctif Partners, EFSA and FSAI co-developed a 2.5-day preparedness training event, comprising an overview of the Regulation on SCBTH, a role-played, 1.5-day simulation exercise and a half-day debrief session. The event, which was held in person at the Convention Centre, Dublin, also involved multiple participants joining online. In addition to rehearsing the development of a multi-agency joint risk assessment (JRA) in response to a SCBTH, the training also aimed to clarify Member State interaction during such a response. The debrief session elicited much discussion and a number of actions were identified as next steps. This debrief session, alongside the identified actions and participants’ responses to the post-event evaluation survey, demonstrate that the training achieved its objectives. There were fifty-one participants in the training event representing four units of European Commission Directorate General on Health and Food Safety (DG SANTE), five EU Agencies and five Member States. Eight facilitators from Instinctif Partners, FSAI and EFSA ensured the smooth and efficient running of the event. This report documents the development, content, conclusions and recommendations of the training event, as well as the participants’ evaluation of it.
Background: Fabry disease (FD) is a rare hereditary multisystem disease caused by variants of the GLA gene. Determination of GLA gene variants and identification of genotype–phenotype correlations allow us to explain the features of FD associated with predominant damage of one or another system, both in the classical and atypical forms of FD, as well as in cases with late manifestation and involvement of one of the systems. Methods: The study included 293 Russian patients with pathogenic variants of the GLA gene, which were identified as a result of various selective screening programs. Screening was carried out for 48,428 high-risk patients using a two-step diagnostic algorithm, including the determination of the concentration of the biomarker lyso-Gb3 as a first-tier test. Screening of atypical FD among patients with HCM was carried out via high-throughput sequencing in another 2427 patients. Results: 102 (0.20%) cases of FD were identified among unrelated patients as a result of the study of 50,855 patients. Molecular genetic testing allowed us to reveal the spectrum and frequencies of 104 different pathogenic variants of the GLA gene in 293 examined patients from 133 families. The spectrum and frequencies of clinical manifestations in patients with FD, including 20 pediatric patients, were described. Correlations between the concentration of the lyso-Gb3 biomarker and the type of pathogenic variants of the GLA gene have been established. Variants identified in patients with early stroke were described, and the association of certain variants with the development of stroke was established. Conclusions: The results of a large-scale selective FD screening, as well as clinical and molecular genetic features, in a cohort of 293 Russian patients with FD are described.